Concord Medical Services (NYSE:CCM) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCMFree Report) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the stock.

Concord Medical Services Stock Performance

NYSE:CCM opened at $5.02 on Thursday. The stock has a 50 day moving average price of $5.54 and a 200 day moving average price of $6.64. The company has a quick ratio of 0.46, a current ratio of 0.47 and a debt-to-equity ratio of 1.15. Concord Medical Services has a one year low of $3.82 and a one year high of $26.70.

Concord Medical Services Company Profile

(Get Free Report)

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Further Reading

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.